Skip to main content

and
  1. Article

    Open Access

    Eteplirsen Treatment for Duchenne Muscular Dystrophy: A Qualitative Patient Experience Study

    Duchenne muscular dystrophy (DMD) is characterized by rapid functional decline. Current available treatment options aim to delay disease progression or stabilize physical function. To aid in healthcare provide...

    Joel Iff, Chloe Carmichael, Stephanie McKee, Ihor Sehinovych in Advances in Therapy (2024)

  2. Article

    Open Access

    Development of a Conceptual Model for the Patient Experience of Immunoglobulin A Nephropathy (IgAN): A Qualitative Literature Review

    Immunoglobulin A nephropathy (IgAN) is a kidney disorder that can lead to progressive kidney disease. Currently, there lacks a comprehensive overview of the symptoms and impacts experienced by those living wit...

    Natalie V. J. Aldhouse, Helen Kitchen, Tamara Al-Zubeidi in Advances in Therapy (2024)

  3. Article

    Open Access

    Development of a Conceptual Model for the Patient Experience of Focal Segmental Glomerulosclerosis (FSGS): A Qualitative Targeted Literature Review

    Focal segmental glomerulosclerosis (FSGS) is a leading cause of kidney disease and can progress to end stage kidney disease (ESKD). An overview of symptoms and impacts of the disease experienced will help info...

    Natalie V. J. Aldhouse, Helen Kitchen, Tamara Al-Zubeidi in Advances in Therapy (2023)

  4. Article

    Open Access

    Key measurement concepts and appropriate clinical outcome assessments in pediatric achondroplasia clinical trials

    This study aimed to identify fit-for-purpose clinical outcome assessments (COAs) to evaluate physical function, as well as social and emotional well-being in clinical trials enrolling a pediatric population wi...

    Natalie V. J. Aldhouse, Helen Kitchen, Chloe Johnson in Orphanet Journal of Rare Diseases (2022)

  5. Article

    Open Access

    Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata

    Eyebrow and eyelash hair loss and nail damage—in addition to scalp hair loss—are important signs/symptoms of alopecia areata (AA) to patients and deserve assessment in AA clinical trials.

    Kathleen W. Wyrwich, Helen Kitchen in American Journal of Clinical Dermatology (2020)

  6. Article

    Open Access

    Cognitive Impairment Associated with Schizophrenia: A Review of the Humanistic Burden

    Nearly every individual with schizophrenia is affected by cognitive decline. The aim of this literature review was to: (a) describe the humanistic burden of cognitive impairment associated with schizophrenia (...

    Helen Kitchen, Diana Rofail, Louise Heron, Pat Sacco in Advances in Therapy (2012)